Partner Nate Lacktman was quoted in a Bloomberg BNA
article, “Telemedicine Providers Anticipating Changes to Remote Prescribing Rules
,” covering the expansion of allowed remote prescriptions of controlled substances.
“We expect the Drug Enforcement Administration (DEA) to release that rule sooner rather than later,” Lacktman said.
He also explained that although there are an increasing amount of states changing their laws to align with remote prescriptions, “some states, in an attempt to reconcile the provisions of the Ryan Haight Act with their own laws, are building the terms of the federal statute directly into their state regulations.” He warned against this practice because it ultimately might not benefit the patients.